BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the fourth quarter and ...
Delivered record quarterly adjusted non-GAAP EBITDA of $50.0 million, an increase of 65.7% year-over-year Diluted GAAP loss per share of $(0.55) and adjusted non-GAAP diluted earnings per share of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results